These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20745437)

  • 1. Ipecacuanha in Emetic Doses: As a Stimulant, Restorative, Eliminative, and Adjuvant, in Various Cases of Disorder and Disease.
    Higginbottom J
    Br Med J; 1869 Feb; 1(426):182-3. PubMed ID: 20745437
    [No Abstract]   [Full Text] [Related]  

  • 2. Ipecacuanha in Emetic Doses: As a Stimulant, Restorative, Eliminative, and Adjuvant, in Various Cases of Disorder and Disease.
    Higginbottom J
    Br Med J; 1869 Feb; 1(424):143-4. PubMed ID: 20745424
    [No Abstract]   [Full Text] [Related]  

  • 3. Ipecacuanha in Emetic Doses: As a Stimulant, Restorative, Eliminative, and Adjuvant, in Various Cases of Disorder and Disease.
    Higginbottom J
    Br Med J; 1869 Feb; 1(425):162-4. PubMed ID: 20745432
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of lerisetron, a new 5-HT3 receptor antagonist, on ipecacuanha-induced emesis in healthy volunteers.
    Cooper M; Sologuren A; Valiente R; Smith J
    Arzneimittelforschung; 2002; 52(9):689-94. PubMed ID: 12404884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ipecacuanha, in Emetic Doses; As a Powerful Restorative in Some Cases of Exhaustion and Sinking.
    Higginbottom J
    Prov Med Surg J; 1846 Jul; 10(26):300-1. PubMed ID: 20794008
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical Studies with Large Non-Emetic Doses of Ipecacuanha: With a Contribution to the Therapeusis of Cholera.
    Woodhull AA
    Atlanta Med Surg J; 1875 Apr; 13(1):10-28. PubMed ID: 35827246
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical Studies with Large Non-Emetic Doses of Ipecacuanha: With a Contribution to the Therapeusis of Cholera.
    Woodhull AA
    Atlanta Med Surg J; 1875 Feb; 12(11):659-673. PubMed ID: 35826532
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical Studies with Large Non-Emetic Doses of Ipecacuanha: With a Contribution to the Therapeusis of Cholera.
    Woodhull AA
    Atlanta Med Surg J; 1875 May; 13(2):80-94. PubMed ID: 35827201
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical Studies with Large Nou-Emetic Doses of Ipecacuanha: With a Contribution to the Therapeusis of Cholera.
    Woodhull AA
    Atlanta Med Surg J; 1875 Mar; 12(12):705-721. PubMed ID: 35826880
    [No Abstract]   [Full Text] [Related]  

  • 10. Syrup of ipecacuanha as an emetic in adults.
    Ilett KF; Gibb SM; Unsworth RW
    Med J Aust; 1977 Jul; 2(3):91-3. PubMed ID: 19691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040.
    Gardner CJ; Twissell DJ; Dale TJ; Gale JD; Jordan CC; Kilpatrick GJ; Bountra C; Ward P
    Br J Pharmacol; 1995 Dec; 116(8):3158-63. PubMed ID: 8719790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ipecacuanha as an emetic.
    Brown GR
    Br Med J; 1977 Nov; 2(6096):1218. PubMed ID: 22376
    [No Abstract]   [Full Text] [Related]  

  • 13. The Non-Emetic Use of Ipecacuanha.
    Ind Med Gaz; 1876 Dec; 11(12):322-325. PubMed ID: 28997749
    [No Abstract]   [Full Text] [Related]  

  • 14. Ipecacuanha in Large Non Emetic Dose in the Treatment of Cholera.
    South Med Rec; 1884 Sep; 14(9):336-337. PubMed ID: 36022509
    [No Abstract]   [Full Text] [Related]  

  • 15. Ipecacuanha as an emetic for adults.
    Gibb SM; Unsworth RW; Ilett KF
    Br Med J; 1977 Dec; 2(6100):1474-5. PubMed ID: 22383
    [No Abstract]   [Full Text] [Related]  

  • 16. Profile of Antiemetic Activity of Netupitant Alone or in Combination with Palonosetron and Dexamethasone in Ferrets and Suncus murinus (House Musk Shrew).
    Rudd JA; Ngan MP; Lu Z; Higgins GA; Giuliano C; Lovati E; Pietra C
    Front Pharmacol; 2016; 7():263. PubMed ID: 27630563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ipecacuanha-induced emesis: a human model for testing antiemetic drug activity.
    Minton N; Swift R; Lawlor C; Mant T; Henry J
    Clin Pharmacol Ther; 1993 Jul; 54(1):53-7. PubMed ID: 8101150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GR205171: a novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activity.
    Gardner CJ; Armour DR; Beattie DT; Gale JD; Hawcock AB; Kilpatrick GJ; Twissell DJ; Ward P
    Regul Pept; 1996 Aug; 65(1):45-53. PubMed ID: 8876035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT3 receptors are not involved in conditioned taste aversions induced by 5-hydroxytryptamine, ipecacuanha or cisplatin.
    Rudd JA; Ngan MP; Wai MK
    Eur J Pharmacol; 1998 Jul; 352(2-3):143-9. PubMed ID: 9716348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ipecacuanha as a Restorative.
    Higginbottom J
    Prov Med Surg J; 1852 Nov; 16(23):584-5. PubMed ID: 20795257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.